Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Sapacitabine

EU orphan designation number: EU/3/08/557   
Active ingredient: Sapacitabine
Indication: Treatment of myelodysplastic syndromes
Sponsor: Cyclacel Limited
Dundee Technopole, James Lindsay Place, Dundee DD1 5JJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/07/2008 Orphan Designation EMEA/OD/014/08 (2008)3594 of 08/07/2008